Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators. Suzuki S, et al. Among authors: suzuki h. Int Heart J. 2015;56(2):213-8. doi: 10.1536/ihj.14-248. Epub 2015 Feb 23. Int Heart J. 2015. PMID: 25740399 Free article. Clinical Trial.
Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing.
Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y. Yoshihisa A, et al. Among authors: suzuki h, suzuki s. Eur J Heart Fail. 2013 May;15(5):543-50. doi: 10.1093/eurjhf/hfs197. Epub 2012 Dec 18. Eur J Heart Fail. 2013. PMID: 23250911 Free article. Clinical Trial.
Suppressive effects of adaptive servo-ventilation on ventricular premature complexes with attenuation of sympathetic nervous activity in heart failure patients with sleep-disordered breathing.
Iwaya S, Yoshihisa A, Nodera M, Owada T, Yamada S, Sato T, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y. Iwaya S, et al. Among authors: suzuki h, suzuki s. Heart Vessels. 2014 Jul;29(4):470-7. doi: 10.1007/s00380-013-0394-2. Epub 2013 Jul 9. Heart Vessels. 2014. PMID: 23836070
Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide.
Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators. Suzuki S, et al. Among authors: suzuki h. J Clin Pharmacol. 2013 Dec;53(12):1277-85. doi: 10.1002/jcph.197. Epub 2013 Oct 19. J Clin Pharmacol. 2013. PMID: 24142853 Free PMC article. Clinical Trial.
Serum cholinesterase is an important prognostic factor in chronic heart failure.
Sato T, Yamauchi H, Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y. Sato T, et al. Among authors: suzuki h, suzuki s. Heart Vessels. 2015 Mar;30(2):204-10. doi: 10.1007/s00380-014-0469-8. Epub 2014 Jan 25. Heart Vessels. 2015. PMID: 24463844
15,296 results
You have reached the last available page of results. Please see the User Guide for more information.